Prudential Financial Inc Syndax Pharmaceuticals Inc Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Prudential Financial Inc holds 38,290 shares of SNDX stock, worth $642,889. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,290

Previous 134,430 71.52%

Holding current value

$642,889

Previous $2.76 Million 73.29%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$17.93 - $24.81 $1.72 Million - $2.39 Million	-96,140 Reduced 71.52%	38,290 $737,000
Q2 2024 Aug 13, 2024	BUY	$18.82 - $23.79 $2.23 Million - $2.82 Million	118,670 Added 752.98%	134,430 $2.76 Million
Q1 2024 May 14, 2024	BUY	$19.71 - $24.57 $310,629 - $387,223	15,760 New	15,760 $375,000
Q3 2023 Nov 13, 2023	SELL	$14.52 - $21.77 $498,036 - $746,711	-34,300 Reduced 20.32%	134,470 $1.95 Million
Q2 2023 Aug 11, 2023	SELL	$19.35 - $22.31 $327,692 - $377,819	-16,935 Reduced 9.12%	168,770 $3.53 Million
Q1 2023 May 12, 2023	BUY	$20.66 - $28.98 $950,979 - $1.33 Million	46,030 Added 32.96%	185,705 $3.92 Million
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $701,863 - $892,291	34,005 Added 32.18%	139,675 $0
Q3 2022 Nov 04, 2022	BUY	$18.51 - $24.79 $1.96 Million - $2.62 Million	105,670 New	105,670 $2.54 Million
Q2 2020 Aug 12, 2020	SELL	$8.94 - $20.98 $108,513 - $254,655	-12,138 Reduced 47.96%	13,170 $195,000
Q1 2020 May 12, 2020	SELL	$6.65 - $12.03 $13,632 - $24,661	-2,050 Reduced 7.49%	25,308 $277,000
Q4 2019 Feb 11, 2020	SELL	$5.43 - $9.22 $1,086 - $1,844	-200 Reduced 0.73%	27,358 $240,000
Q3 2019 Nov 13, 2019	BUY	$7.47 - $10.76 $48,166 - $69,380	6,448 Added 30.54%	27,558 $205,000
Q2 2019 Aug 08, 2019	BUY	$4.9 - $9.31 $103,439 - $196,534	21,110 New	21,110 $0

Others Institutions Holding SNDX

# of Institutions

225

Shares Held

88.2M

Call Options Held

953K

Put Options Held

653K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $950M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Syndax Pharmaceuticals Inc Transaction History